Slate Medicines: Funding, Investors & Team (Oct 2026)
Slate Medicines is a biotechnology company that develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention. The company aims to revolutionize migraine prevention for patients seeking alternative solutions.
Slate Medicines has raised $130M across 1 funding round on record, the most recent a Series A of $130M announced in Feb 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Slate Medicines Company Profile and Key Stats
Latest funding round on record: Feb 2026.
Slate Medicines Funding Rounds
Slate Medicines Founders and Leadership Team
No contact details are on record for this team yet.
Slate Medicines Funding Compared to Other Biotechnology Startups
Slate Medicines' latest round of $130M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Slate Medicines in Biotechnology and Raleigh
Companies Similar to Slate Medicines
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Slate Medicines Funding FAQs
What does Slate Medicines do?
Slate Medicines is a biotechnology company that develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention. The company aims to revolutionize migraine prevention for patients seeking alternative solutions.
How much funding has Slate Medicines raised?
Slate Medicines has raised $130M across 1 round on record. The most recent is a Series A of $130M announced in Feb 2026.
When did Slate Medicines last raise funding?
Slate Medicines' most recent funding round on record is a Series A of $130M, announced in Feb 2026.
Who founded Slate Medicines?
FundedIQ lists Neil Buckley (Founder) at Slate Medicines.
Where is Slate Medicines headquartered?
Slate Medicines is based in Raleigh, North Carolina, United States.
How many employees does Slate Medicines have?
Slate Medicines is in the 1-10 employee band.
How does Slate Medicines' funding compare to other Biotechnology startups?
Slate Medicines' latest round of $130M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Slate Medicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Slate Medicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.